ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 116 filers reported holding ANAPTYSBIO INC in Q3 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180 | -85.7% | 10 | -83.9% | 0.00% | – |
| Q2 2023 | $1,261 | +478.4% | 62 | +520.0% | 0.00% | – |
| Q1 2023 | $218 | -29.7% | 10 | 0.0% | 0.00% | – |
| Q4 2022 | $310 | – | 10 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 10 | +66.7% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 6 | -97.9% | 0.00% | – |
| Q2 2018 | $20,000 | +100.0% | 282 | +182.0% | 0.00% | – |
| Q1 2018 | $10,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |